Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.5M Buy
314,309
+522
+0.2% +$47.6K 0.17% 84
2026
Q1
$32.2M Buy
313,787
+39,547
+14% +$4.47M 0.23% 71
2025
Q4
$34.4M Buy
274,240
+15,650
+6% +$1.99M 0.26% 61
2025
Q3
$34.6M Sell
258,590
-31,276
-11% -$4.11M 0.27% 49
2025
Q2
$39.4M Buy
289,866
+15,577
+6% +$2.05M 0.33% 41
2025
Q1
$36.4M Buy
274,289
+5,637
+2% +$717K 0.35% 40
2024
Q4
$30.4M Buy
268,652
+26,192
+11% +$3.03M 0.28% 45
2024
Q3
$27.6M Buy
242,460
+2,949
+1% +$323K 0.27% 53
2024
Q2
$24.9M Sell
239,511
-11,115
-4% -$1.18M 0.25% 55
2024
Q1
$28.5M Buy
250,626
+14,720
+6% +$1.69M 0.3% 51
2023
Q4
$26M Buy
235,906
+17,809
+8% +$1.78M 0.31% 51
2023
Q3
$21.1M Buy
218,097
+3,702
+2% +$389K 0.29% 58
2023
Q2
$23.4M Sell
214,395
-19,755
-8% -$2.11M 0.31% 52
2023
Q1
$23.7M Sell
234,150
-1,701
-0.7% -$180K 0.35% 51
2022
Q4
$25.9M Buy
235,851
+33,815
+17% +$3.5M 0.42% 41
2022
Q3
$19.5M Buy
202,036
+25,286
+14% +$2.7M 0.38% 42
2022
Q2
$19.2M Sell
176,750
-55,417
-24% -$6.29M 0.39% 44
2022
Q1
$27.5M Buy
232,167
+29,433
+15% +$3.65M 0.46% 32
2021
Q4
$28.5M Buy
202,734
+24,648
+14% +$3.15M 0.45% 34
2021
Q3
$21M Sell
178,086
-22,843
-11% -$2.81M 0.4% 40
2021
Q2
$23.3M Sell
200,929
-6,517
-3% -$760K 0.43% 40
2021
Q1
$24.9M Sell
207,446
-688
-0.3% -$81.5K 0.53% 35
2020
Q4
$22.8M Buy
208,134
+2,135
+1% +$232K 0.5% 36
2020
Q3
$22.4M Buy
205,999
+17,459
+9% +$1.77M 0.55% 32
2020
Q2
$17.2M Buy
+188,540
New +$17M 0.44% 45

Other funds holding ABT

Xponance's ABT Position: Q2 2026 in Review

Xponance increased its Abbott (ABT) stake by 0.17% in Q2 2026, buying an estimated $47.6K and bringing the position to 314,309 shares worth $28.5M. The position accounts for 0.17% of the portfolio, ranked #84.

Xponance first reported a position in ABT in Q2 2020 and has held it in 25 quarters since. The position peaked at $39.4M in Q2 2025. 2,964 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

  • Xponance held 314,309 shares of Abbott worth $28.5M as of Q2 2026.
  • Xponance bought 522 Abbott shares in Q2 2026, an estimated $47.6K.
  • Abbott made up 0.17% of Xponance's portfolio in Q2 2026, its #84 holding.
  • Xponance first reported a position in Abbott in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Abbott position peaked at $39.4M in Q2 2025.
  • 2,964 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.